Christopher Mores

Dr. Mores is a virologist and epidemiologist, who studies emerging infectious diseases and their impacts. He is a Professor in the Department of Global Health at the Milken Institute School of Public Health, George Washington University. There, he is the Director of the Global Health Epidemiology and Disease Control MPH Program, and Director of a high containment research laboratory, from which he led SARS-CoV-2 studies in response to the pandemic, Mpox investigations during the 2022- outbreak, and ongoing studies into chikungunya pathogenesis and treatment. 

He holds a Master of Science in Tropical Public Health and a Doctor of Science in Immunology and Infectious Diseases from Harvard University. Dr. Mores completed postdoctoral training in vector-borne and viral hemorrhagic fever viruses as a National Research Council Fellow at the United States Army Medical Research Institute for Infectious Diseases (USAMRIID). He has held professorships at the University of Florida and Louisiana State University where he investigated numerous outbreaks and led laboratories researching pathogen emergence. Dr. Mores responded to the West Africa ebolavirus outbreak in 2014-15 with the Irish NGO GOAL as an infection prevention and control specialist and surveillance lead. He was previously the head of the Virology and Emerging Infections Department at the US Naval Research Unit No. 6 in Peru, during which he investigated the initial Zika virus outbreak in the Americas and many other viral diseases. With the US CDC, he was engaged in ebola outbreak response activities and investigations in the Democratic Republic of the Congo from 2020-23. Dr. Mores is currently engaged in global health programs across 5 continents with a mix of government, industry and foundation partners. He continues to advise the US government and industry on countermeasures to emerging disease threats and enhancements to health system resiliency.